Skip to main content
Hit enter to search or ESC to close
Close Search
Hepion PharmaceuticalsHepion Pharmaceuticals
Menu
  • About
    • Company Overview
    • Executive Team
    • Board of Directors
    • Partnering
  • Hepatocellular Carcinoma
  • Portfolio
  • Newsroom
  • Investors
    • Investor Overview
    • Press Releases
    • Presentations
    • Company Information
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • Contact
    • Contact Us
    • Careers
  • linkedin
Hepion Pharmaceuticals
Media Placements

Fatty Liver, NASH, Cirrohosis – Can They Be Stopped??? [BioTech Nation]

By HepionApril 13, 2023No Comments

Fatty Liver, NASH, Cirrohosis – Can They Be Stopped??? [BioTech Nation]

https://www.biotechnation.com/episodes/fatty-liver-nash-cirrohosis-can-they-be-stopped
About
Leadership
Hepatocellular Carcinoma
Newsroom
Investors
Contact
Subscribe for Updates

© 2026 Hepion Pharmaceuticals | Disclaimer & Terms of Use

Share
Share Share Share Pin
Close Menu
  • About
    • Company Overview
    • Executive Team
    • Board of Directors
    • Partnering
  • Hepatocellular Carcinoma
  • Portfolio
  • Newsroom
  • Investors
    • Investor Overview
    • Press Releases
    • Presentations
    • Company Information
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • Contact
    • Contact Us
    • Careers
  • linkedin